Innovation
Medicilon large animal models such as non-human primates, dogs, rabbits, and miniature pigs have shown unique advantages and value in key areas of drug development
With the advent of the era of precision medicine and the deepening understanding of disease mechanisms, large animal models such as non-human primates, dogs, rabbits, and miniature pigs have shown unique advantages and value in key areas of drug development. ...
Navigating the EU’s General Product Safety Regulations (GPSR)
Webinar on Tuesday, 10 December 2024, from 1:00 PM to 2:30 PM UK Time to help businesses prepare for the General Product Safety Regulation (GPSR) deadline on 13 December 2024. ...
Mills & Reeve advises university spin-out on £2.1m funding
Leading national law firm Mills & Reeve has advised University of Cambridge spin- out, Illumion, on a £2.1 million seed funding round. ...
Allia celebrates 25 years of driving social impact
Empowering 4,039 ventures, supporting 520 tenants, and arranged and advised on over £4 billion of finance since 1999. ...
Anne Rosette - where is your next Holiday? Even your next investment?
The CEO of the Seychelles Investment Board (SIB) reveals the Country's SDG Investor Map on her visit to Cambridge. Anne Rosette was on a mission to recruit High Networth Individuals and institutional investors who are out for new investment opportunities in international markets. So, wi...
Cambridge AI Club for Biomedicine - December 2024
The AI Club brings together the Biomedical AI and Machine Learning community in Cambridge, to discuss common themes and explore different topics and methodologies. Talks will be followed by pizza and networking. ...
High opacity micro 3D printing - Tough Carbon Black
Revolutionizing Micro 3D Printing with Tough Carbon Black
Targeting IL-23, Medicilon assists the development of a variety of new drugs for Psoriasis
With people’s in-depth understanding of the inflammatory pathways of psoriasis, biologics continue to develop. From tumor necrosis factor alpha (TNF-α), to IL-17 inhibitors, and then to IL-23 inhibitors, biologics have brought new light to the treatment of psoriasis again. In recent y...
Cambridge NeuroWorks Launch Event - Powered by ARIA
Join us for the launch of Cambridge NeuroWorks, an ambitious multi-million-pound, three-year partnership with the Advanced Research and Invention Agency (ARIA) to revolutionise neurotechnology. ...
Un-scrunching marketing minds and replenishing original thought in the workplace
Un-creative thinking is learned. The question is, can we unlearn it? In this interactive, marketing-focused workshop, Creativity Director Chloe Ambrose will explore why we need to invest in creative thinking and where we can get started. ...